Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 210

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Potential of Allogeneic Adipose-Derived Stem Cell–Hydrogel Complex for Treating Diabetic Foot Ulcers

Moon, Kyung-Chul, Suh, Hyun-Suk, Kim, Ki-Bum, Han, Seung-Kyu, Young, Ki-Won, Lee, Jin-Woo, Kim, Mi-Hyung·2019·Diabetes

Abstract

Mesenchymal stem cells (MSCs) may hold great promise for treating diabetic wounds. However, it is difficult for a clinician to use MSCs because they have not been commercialized. Meanwhile, a new commercial drug that contains adipose-derived stem cells (ASCs) has been developed. The purpose of this study was to examine the potential of allogeneic ASC sheets for treating diabetic foot ulcers. Fifty-nine patients with diabetic foot ulcers were randomized to either the ASC treatment group (n = 30) or a control group treated with polyurethane film (n = 29). Either an allogeneic ASC sheet or polyurethane film was applied on diabetic wounds weekly. These wounds were evaluated for a maximum of 12 weeks. Complete wound closure was achieved for 73% in the treatment group and 47% in the control group at week 8. Complete wound closure was achieved for 82% in the treatment group and 53% in the control group at week 12. The Kaplan-Meier median times to complete closure were 28.5 and 63.0 days for the treatment group and the control group, respectively. There were no serious adverse events related to allogeneic ASC treatment. Thus, allogeneic ASCs might be effective and safe to treat diabetic foot ulcers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db18-0699

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 37

  1. Han, 2005, Potential of human bone marrow stromal cells to accelerate wound healing in vitro, Ann Plast Surg, 55, 414, 10.1097/01.sap.0000178809.01289.10 · doi:10.1097/01.sap.0000178809.01289.10
  2. Conget, 1999, Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells, J Cell Physiol, 181, 67, 10.1002/(SICI)1097-4652(199910)181:1<67::AID-JCP7>3.0.CO;2-C · DOI · Paper page
  3. Kim, 2010, Effect of human bone marrow stromal cell allograft on proliferation and collagen synthesis of diabetic fibroblasts in vitro, J Plast Reconstr Aesthet Surg, 63, 1030, 10.1016/j.bjps.2009.04.006 · doi:10.1016/j.bjps.2009.04.006
  4. Lee, 2007, Effect of human bone marrow stromal cells and dermal fibroblasts on collagen synthesis and epithelization, Ann Plast Surg, 59, 713, 10.1097/SAP.0b013e318036aadf · doi:10.1097/sap.0b013e318036aadf
  5. Han, 2006, The effect of human bone marrow stromal cells and dermal fibroblasts on angiogenesis, Plast Reconstr Surg, 117, 829, 10.1097/01.prs.0000201458.80364.31 · doi:10.1097/01.prs.0000201458.80364.31
  6. Tabatabaei Qomi, 2017, Adipose-derived stromal cell in regenerative medicine: a review, World J Stem Cells, 9, 107, 10.4252/wjsc.v9.i8.107 · DOI
  7. Bora, 2017, Adipose tissue-derived stromal vascular fraction in regenerative medicine: a brief review on biology and translation, Stem Cell Res Ther, 8, 145, 10.1186/s13287-017-0598-y · DOI · Paper page
  8. Maria, 2016, Adipose mesenchymal stromal cells minimize and repair radiation-induced oral mucositis, Cytotherapy, 18, 1129, 10.1016/j.jcyt.2016.06.008 · DOI
  9. Cao, 2017, Mesenchymal stem cells improve healing of diabetic foot ulcer, J Diabetes Res, 2017, 9328347, 10.1155/2017/9328347 · DOI · Paper page
  10. Kato, 2015, Allogeneic transplantation of an adipose-derived stem cell sheet combined with artificial skin accelerates wound healing in a rat wound model of type 2 diabetes and obesity, Diabetes, 64, 2723, 10.2337/db14-1133 · DOI · Paper page
  11. McLaughlin, 2013, The use of adipose-derived stem cells as sheets for wound healing, Organogenesis, 9, 79, 10.4161/org.24946 · doi:10.4161/org.24946
  12. You, 2012, Treatment of diabetic foot ulcers using cultured allogeneic keratinocytes—a pilot study, Wound Repair Regen, 20, 491, 10.1111/j.1524-475X.2012.00809.x · DOI
  13. Lavery, 2014, The efficacy and safety of Grafix for the treatment of chronic diabetic foot ulcers: results of a multi-centre, controlled, randomised, blinded, clinical trial, Int Wound J, 11, 554, 10.1111/iwj.12329 · DOI · Paper page
  14. Huebner, 2015, The stochastically curtailed generalized likelihood ratio: a new termination criterion for variable-length computerized classification tests, Behav Res Methods, 47, 549, 10.3758/s13428-014-0490-y · doi:10.3758/s13428-014-0490-y
  15. Falanga, 1998, Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent, Arch Dermatol, 134, 293, 10.1001/archderm.134.3.293 · DOI · Paper page
  16. Briscoe, 1999, The allogeneic response to cultured human skin equivalent in the hu-PBL-SCID mouse model of skin rejection, Transplantation, 67, 1590, 10.1097/00007890-199906270-00014 · DOI · Paper page
  17. Marston, 2003, The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial, Diabetes Care, 26, 1701, 10.2337/diacare.26.6.1701 · DOI · Paper page
  18. Steinberg, 2010, Confirmatory data from EU study supports Apligraf for the treatment of neuropathic diabetic foot ulcers, J Am Podiatr Med Assoc, 100, 73, 10.7547/1000073 · DOI
  19. Han, 2004, Clinical application of fresh fibroblast allografts for the treatment of diabetic foot ulcers: a pilot study, Plast Reconstr Surg, 114, 1783, 10.1097/01.PRS.0000142415.57470.DF · DOI
  20. Han, 2009, Efficacy and safety of fresh fibroblast allografts in the treatment of diabetic foot ulcers, Dermatol Surg, 35, 1342, 10.1111/j.1524-4725.2009.01239.x · DOI
  21. Hehenberger, 1998, Inhibited proliferation of fibroblasts derived from chronic diabetic wounds and normal dermal fibroblasts treated with high glucose is associated with increased formation of l-lactate, Wound Repair Regen, 6, 135, 10.1046/j.1524-475X.1998.60207.x · DOI · Paper page
  22. Moon, 2017, Effects of human umbilical cord blood-derived mesenchymal stromal cells and dermal fibroblasts on diabetic wound healing, Cytotherapy, 19, 821, 10.1016/j.jcyt.2017.03.074 · DOI
  23. You, 2014, Cell therapy for wound healing, J Korean Med Sci, 29, 311, 10.3346/jkms.2014.29.3.311 · DOI · Paper page
  24. Kaisang, 2017, Adipose-derived stem cells seeded in Pluronic F-127 hydrogel promotes diabetic wound healing, J Surg Res, 217, 63, 10.1016/j.jss.2017.04.032 · DOI
  25. Madonna, 2014, Transplantation of mesenchymal cells improves peripheral limb ischemia in diabetic rats, Mol Biotechnol, 56, 438, 10.1007/s12033-014-9735-3 · DOI
  26. Cianfarani, 2013, Diabetes impairs adipose tissue-derived stem cell function and efficiency in promoting wound healing, Wound Repair Regen, 21, 545, 10.1111/wrr.12051 · DOI · Paper page
  27. Shin, 2013, Human mesenchymal stem cell grafts enhance normal and impaired wound healing by recruiting existing endogenous tissue stem/progenitor cells, Stem Cells Transl Med, 2, 33, 10.5966/sctm.2012-0041 · DOI
  28. Falanga, 2005, Wound healing and its impairment in the diabetic foot, Lancet, 366, 1736, 10.1016/S0140-6736(05)67700-8 · DOI · Paper page
  29. Boulton, 2005, The global burden of diabetic foot disease, Lancet, 366, 1719, 10.1016/S0140-6736(05)67698-2 · DOI · Paper page
  30. Bolton, 2016, Quality randomized clinical trials of topical diabetic foot ulcer healing agents, Adv Wound Care (New Rochelle), 5, 137, 10.1089/wound.2014.0571 · DOI
  31. Veves, 2001, Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial, Diabetes Care, 24, 290, 10.2337/diacare.24.2.290 · DOI · Paper page
  32. DiDomenico, 2018, Use of an aseptically processed, dehydrated human amnion and chorion membrane improves likelihood and rate of healing in chronic diabetic foot ulcers: a prospective, randomised, multi-centre clinical trial in 80 patients, Int Wound J, 15, 950, 10.1111/iwj.12954 · DOI
  33. Tettelbach, 2019, A confirmatory study on the efficacy of dehydrated human amnion/chorion membrane dHACM allograft in the management of diabetic foot ulcers: a prospective, multicentre, randomised, controlled study of 110 patients from 14 wound clinics, Int Wound J, 16, 19, 10.1111/iwj.12976 · DOI
  34. Park, 2018, Topical epidermal growth factor spray for the treatment of chronic diabetic foot ulcers: a phase III multicenter, double-blind, randomized, placebo-controlled trial, Diabetes Res Clin Pract, 142, 335, 10.1016/j.diabres.2018.06.002 · DOI
  35. Han, 2010, The treatment of diabetic foot ulcers with uncultured, processed lipoaspirate cells: a pilot study, Wound Repair Regen, 18, 342, 10.1111/j.1524-475X.2010.00593.x · DOI
  36. Bender, 2001, Adjusting for multiple testing—when and how, J Clin Epidemiol, 54, 343, 10.1016/S0895-4356(00)00314-0 · DOI · Paper page
  37. Wason, 2014, Correcting for multiple-testing in multi-arm trials: is it necessary and is it done, Trials, 15, 364, 10.1186/1745-6215-15-364 · DOI · Paper page

Cited by

See all 210

Metadata

Authors
Moon, K.-C., Suh, H.-S., Kim, K.-B., Han, S.-K., Young, K.-W., Lee, J.-W., & Kim, M.-H.
Venue
Diabetes
Published
2019-01-24
Volume
68
Issue
4
Pages
837-846
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2914231757
Cited by
210
References
1
FWCI
12.85
Type
journal article
Language
en
Open access
closed
Funders
  • Anterogen
  • Ministry of Health & Welfare, Republic of Korea (HI16C1037)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Potential of Allogeneic Adipose-Derived Stem Cell–Hydrogel Complex for Treating Diabetic Foot Ulcers. https://app.cochat.ai/papers/10.2337/db18-0699
The paper
Moon, K.-C., Suh, H.-S., Kim, K.-B., Han, S.-K., Young, K.-W., Lee, J.-W., & Kim, M.-H. (2019). Potential of Allogeneic Adipose-Derived Stem Cell–Hydrogel Complex for Treating Diabetic Foot Ulcers. Diabetes. https://doi.org/10.2337/db18-0699

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.